Negandhi Himanshu, Tiwari Ritika, Sharma Anjali, Nair Rajesh, Zodpey Sanjay, Reddy Allam Ramesh, Oruganti Ganesh
a Indian Institute of Public Health - Delhi , Public Health Foundation of India , Gurgaon , India.
b Public Health Foundation of India , Gurgaon , India.
Glob Health Action. 2017;10(1):1290315. doi: 10.1080/16549716.2017.1290315.
The Revised National Tuberculosis Control Program (RNTCP) is the largest tuberculosis (TB) control program in the world based on Directly Observed Treatment Short-Course (DOTS) strategy. Globally, most countries have been using a daily regimen and in India a shift towards a daily regimen for TB treatment has already begun. The daily strategy is known to improve program coverage along with compliance. Such strategic shifts have both management and operational implications. We undertook a rapid assessment to understand the facilitators and barriers in adopting the daily regimen for TB treatment in three Indian states.
In-depth interviews were planned across six districts of three purposively selected states of Maharashtra, Bihar and Sikkim, among health system personnel at various levels to identify their perspectives on adoption of a daily regimen for TB. These districts were sampled on the basis of TB notification rates. Thematic analysis of the qualitative data was undertaken.
62 respondents were interviewed from these 6 districts. During the analysis, it was observed that an easily accessible, patient-centred and personalized outreach is an enabling factor for adherence to treatment. Lack of transportation facilities, out-of-pocket expenses and loss of wages for accessing DOTS at institutions are major identified barriers for treatment adherence at individual level. At program level, lack of trained service providers, poor administration of treatment protocols and inadequate supervision by health care providers and program managers are key factors that influence program outcomes.
A major observation that emerged from the interviews is that the key to achieve a relapse-free cure is ensuring that a patient receives all doses of the prescribed treatment regimen. However, switching to a daily regimen makes adherence difficult and thus new strategies are needed for its implementation at patient and health provider levels. Most stakeholders appreciate the reasons for switching to a daily regimen. The stakeholders recognised the efforts of the Ministry of Health & Family Welfare (MoHFW) in spearheading the program. Strategies like the 99 DOTS call-centre approach may also further ensure treatment adherence.
修订后的国家结核病控制规划(RNTCP)是全球最大的基于直接观察短程治疗(DOTS)策略的结核病控制规划。在全球范围内,大多数国家一直采用每日治疗方案,并且在印度,结核病治疗已开始转向每日治疗方案。众所周知,每日治疗策略有助于提高规划覆盖率和治疗依从性。这种策略转变具有管理和操作层面的影响。我们进行了一项快速评估,以了解印度三个邦采用结核病每日治疗方案的促进因素和障碍。
我们计划在马哈拉施特拉邦、比哈尔邦和锡金邦这三个经过有目的选择的邦的六个区,对各级卫生系统人员进行深入访谈,以了解他们对采用结核病每日治疗方案的看法。这些区是根据结核病通报率进行抽样的。对定性数据进行了主题分析。
从这6个区共访谈了62名受访者。在分析过程中发现,便捷、以患者为中心且个性化的外展服务是坚持治疗的一个促进因素。交通设施不足、自付费用以及前往机构接受DOTS治疗导致的工资损失是在个体层面确定的治疗依从性的主要障碍。在规划层面,缺乏训练有素的服务提供者、治疗方案管理不善以及医疗服务提供者和规划管理人员监督不足是影响规划结果的关键因素。
访谈得出的一个主要观察结果是,实现无复发病愈的关键是确保患者接受规定治疗方案的所有剂量。然而,转向每日治疗方案使依从性变得困难,因此需要在患者和卫生服务提供者层面实施新的策略。大多数利益相关者理解转向每日治疗方案的原因。利益相关者认可卫生与家庭福利部(MoHFW)在牵头实施该规划方面所做的努力。像99 DOTS呼叫中心方法这样的策略也可能进一步确保治疗依从性。